SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
MAY 3, 2005
GENOMED, INC.
(Exact name of registrant as specified in its charter)
----------------------------- --- ------------------ --- -----------------------
FLORIDA 000-49720 43-1916702
----------------------------- --- ------------------ --- -----------------------
(State or other jurisdiction (Commission file (IRS Employer
of incorporation) number) Identification Number)
----------------------------- --- ------------------ --- -----------------------
9666 OLIVE BLVD., SUITE 310, ST. LOUIS, MISSOURI 63132
------------------------------------------------------
(Address of principal executive offices) (Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:
---------------------------------------------------
(314) 983-9933
ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
(a) The registrant's independent auditor, Rubin, Brown, Gornstein & Co., LLP
("RBG") declined to stand for reelection, and, effective May 3, 2005, RBG
was dismissed.
The report of RBG on the financial statements for the year ended December
31, 2004 contained no adverse opinion or disclaimer of opinion and was not
qualified or modified as to uncertainty, audit scope or accounting
principle, except that the report for the year ended December 31, 2004
contained an explanatory paragraph expressing doubt about the Registrant's
ability to continue as a going concern.
RBG served as the auditor during the most recent fiscal year of the
registrant (2004), and during that time there has been no disagreement with
RBG on any matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure, which if not resolved
to the satisfaction of RBG, would have caused it to make reference to the
subject matter of the disagreement in connection with its report.
The registrant has authorized RBG to respond fully to any inquiries of its
new auditor concerning any issue relating to the registrant's accounting
principles or practices or financial reporting, the registrant's financial
statements or RBG's audit thereof or audit opinions thereon.
The registrant has provided a copy of the disclosures in this report to
RBG. Any letter from RBG pursuant to paragraph (a)(3) of Regulation S-K
will be supplied by amendment.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
------------------------------------ -------------------------------------------
GenoMed, Inc.
Dated: May 6, 2005 By: /s/ Dr. David Moskowitz
--------------------------------
Dr. David Moskowitz
Chairman of the Board and
Chief Executive Officer
------------------------------------ -------------------------------------------